US Patent 10046040 Multivalent live vector vaccine against
Patent 10046040 was granted and assigned to University of Maryland, Baltimore on August, 2018 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 10046040 Multivalent live vector vaccine against
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
